LIVE SESSION BRIEF Drug Manufacturers - Specialty & Generic $1.46B Cap Quant: BUY

Avadel Pharmaceuticals plc Ordinary Share (AVDL) โ€” Live Session & Technical Brief

Updated Nov 22, 2026 5:09 AM ET ยท Prev Close $21.63

Pro Workspace
Last Session Price
$21.64 +0.05%
+$0.01 vs $21.63 prior close
Intraday Range
$21.63 โ€“ $21.76
Open $21.66
Relative Volume
22.59x Avg
34,979,225 sh
52-Week Range
$6.38 โ€“ $23.57
Benchmark Alpha
+3.69% vs SPY
+5.72% vs QQQ
20-Session Trend +0.7%

Session Regime & Catalyst Assessment

64% Signal Conviction
TECHNICAL 64% Driver Weight

Controlled Session Consolidation (+0.05%) in Drug Manufacturers - Specialty & Generic

Avadel Pharmaceuticals plc Ordinary Share (AVDL) is trading within a tight intraday band at $21.64 (+0.05%, 22.59x relative volume), signaling orderly institutional price discovery without an outlier shock. Relative to benchmarks, AVDL is outperforming the S&P 500 by +3.69%. 14-day RSI stands at 62.3, keeping momentum in a bullish regime.

NEWS 70% Weight
Alkermes Completes Acquisition of Avadel

Alkermes ALKS completed its acquisition of Avadel Pharmaceuticals AVDL following the Irish High

TECHNICAL 68% Weight
Moving Average Structure: Bullish Alignment

Price ($21.64) holds above both 20-day ($21.56) and 50-day ($21.50) moving averages.

Volume Confirmation
HIGH VOLUME (22.59x) Accumulation
Institutional participation confirms directional price action.
Composite Catalyst Confidence 64%
Cross-checked across volume tape, benchmark alpha, options flow, and news.

Market & Sector Relative Strength

AVDL outperforming the S&P 500 by +3.69%
AVDL Session
+0.05%
$21.64
S&P 500 (SPY)
-3.64%
$689.81
Nasdaq 100 (QQQ)
-5.67%
$608.45
Healthcare (XLV)
-0.12%
$177.24
Alpha vs SPY: +3.69% Alpha vs QQQ: +5.72% Alpha vs XLV: +0.17%

Recent AVDL Catalyst Headlines

Verified Wire
Form 8.3 - Avadel Pharmaceuticals plc

FORM 8.3 Irish Takeover Panel Disclosure Under Rule 8.3 Of the Irish Takeover Panel Act, 1997, Takeover Rules, 2013 Dealings by Persons With Interests in Relevant Securities Representing 1 or More 1. Key Information Name

Yahoo Finance ยท Feb 12, 2026
Form 8.3 -Avadel Pharmaceuticals plc

FORM 8.3 Irish Takeover Panel Disclosure Under Rule 8.3 Of the Irish Takeover Panel Act, 1997, Takeover Rules, 2013 Dealings by Persons With Interests in Relevant Securities Representing 1 or More 1. Key Information Name

Yahoo Finance ยท Feb 11, 2026

1โ€“3 Day Expected Range & Key Level

54% Follow-Through
Lower Bound
$21.16
Short-term support band
Upper Bound
$22.12
Short-term resistance band
Key Inflection Level
$21.56 (20-day SMA support)

Monitor volume expansion above 1.5x RVOL around $21.56 (20-day SMA support) for directional breakout confirmation.

Technical Regime (AVDL)

BULLISH MA TREND
RSI (14)
62.3
Bullish
20-Day SMA
$21.56
Above 20d
50-Day SMA
$21.50
Above 50d
MACD Signal
Bullish
MACD 0.05
ADX (14)
47.3
Strong trend
10d Momentum
+0.10
Positive 10-day momentum

Retail & Crowd Sentiment

Neutral
24h Messages
0
7d avg 0.0
Bullish / Bearish
0.0% / 0.0%
None buzz
Crowd Discussion Digest

Qube Research & Technologies Limited disclosed interests and short positions in Avadel Pharmaceuticals plc in an Irish Takeover Panel Opening Position Disclosure, representing 1.18% of the company's $0.01 ordinary shares.

Reddit communities: 1 comment (Neutral)

About Avadel Pharmaceuticals plc Ordinary Share

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, โ€ฆ

Sector
Healthcare
Market Cap
$1.46B
Forward P/E
17.9x
Employees
188

Get Instant AVDL Catalyst Alerts

Receive an email alert when AVDL triggers an unusual volume breakout, options sweep, or rating shift.

AVDL Session & Catalyst FAQ

Why is AVDL stock trading near flat today?

Avadel Pharmaceuticals plc Ordinary Share (AVDL) is trading within a tight intraday band at $21.64 (+0.05%, 22.59x relative volume), signaling orderly institutional price discovery without an outlier shock. Relative to benchmarks, AVDL is outperforming the S&P 500 by +3.69%. 14-day RSI stands at 62.3, keeping momentum in a bullish regime.

Is AVDL stock a buy or sell right now?

Today's session carries a 64% catalyst conviction score on 22.59x relative volume (high participation). Our multi-factor model currently rates AVDL as BUY. Review full valuation, quality, and timing signals on the AVDL Buy or Sell Decision Brief โ†’

What is AVDL's intrinsic value and expected trading range?

At $21.64, AVDL's modeled 1-to-3 session range is $21.16 โ€“ $22.12, with a key inflection level at $21.56 (20-day SMA support). Compare current price against multi-year cash flow projections in the AVDL Intrinsic Value & DCF Model โ†’ and Market Cycle Phase Tracker โ†’

What do RSI and moving averages signal for AVDL?

RSI at 62.3 reflects constructive bullish momentum. AVDL trades at $21.64 relative to its 20-day SMA ($21.56) and 50-day SMA ($21.50), reflecting a bullish moving-average structure.

Tradestie Flagship Research & Market Hubs